Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction

Cell Death and Differentiation
Béatrice Bailly-MaitreRoger Rahmani

Abstract

We examined the effects of dexamethasone (DEX) on the apoptotic process in primary cultures of human and rat hepatocytes. DEX prolonged cell viability, inhibited the development of an apoptotic morphology, and stabilised the expression of procaspase-3 in both human and rat hepatocytes. In addition, the inhibition of apoptosis by DEX was strongly correlated with a decrease of caspase-3-like protease activity. Moreover, DEX treatment increased the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins in human and rat hepatocytes, respectively, whereas the expression of pro-apoptotic proteins Bcl-xS or Bad was not detected or remained unchanged. The bcl-xL transcript is regulated at the transcriptional level and its expression paralleled that of Bcl-xL protein in DEX-treated rat hepatocytes. Taken together, these results indicate that this glucocorticoid exerts a protective role on cell survival and it delays apoptosis of human and rat hepatocytes by modulating caspase-3-like protease activity and bcl-2 and bcl-x gene expression.

References

Feb 1, 1979·Journal of Cellular Physiology·J M HarmonE B Thompson
Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Feb 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N BansalG Melnykovych
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Jan 1, 1994·Annual Review of Biochemistry·M J Tsai, B W O'Malley
Jan 1, 1996·Genes & Development·E White
Mar 15, 1996·The Journal of Biological Chemistry·A J MinnC B Thompson
Oct 18, 1996·Cell·E S AlnemriJ Yuan
Nov 15, 1996·Cell·T F Gajewski, C B Thompson
Feb 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·I J McEwanJ A Gustafsson
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Jan 1, 1997·Journal of Hepatology·G Feldmann
Jul 31, 1997·Nature·G MelinoA Finazzi-Agro
Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YamamotoY Komatsu
May 23, 1998·The Journal of Biological Chemistry·R U JänickeA G Porter
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H C Pitot
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L FalascaL Conti Devirgiliis
Sep 12, 1998·Science·J M Adams, S Cory
Dec 22, 1999·The Journal of Experimental Medicine·N J KennedyR C Budd
Sep 1, 1992·Trends in Cell Biology·G T WilliamsE A Grimes

❮ Previous
Next ❯

Citations

Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ingrid HerrMarkus W Büchler
Nov 5, 2003·Chemico-biological Interactions·Rebecca L UzarskiJames J Pestka
Jun 1, 2002·Molecular and Cellular Endocrinology·Abraham Amsterdam, Ravid Sasson
May 7, 2009·Journal of Lipid Research·Joana D AmaralCecília M P Rodrigues
Mar 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jin-Moo LeeJan Xu
Sep 10, 2013·Archives of Toxicology·Mathieu VinkenVera Rogiers
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Béatrice Bailly-MaitreJohn C Reed
Apr 12, 2011·Archives of Toxicology·Mathieu VinkenVera Rogiers
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Tríona Ní ChonghaileAfshin Samali
Mar 5, 2013·Expert Opinion on Drug Metabolism & Toxicology·Tom De BruynPieter Annaert
Jan 10, 2012·Colloids and Surfaces. B, Biointerfaces·Ilaria FratoddiMaria V Russo
Jul 8, 2010·The Journal of Surgical Research·Antonio IannelliRoger Rahmani
Dec 17, 2009·Transplantation Proceedings·A IannelliR Rahmani
Oct 31, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonello PetrellaLuca Parente
Nov 25, 2003·British Journal of Haematology·Françoise Debierre-GrockiegoValérie Gouilleux-Gruart
Aug 30, 2008·Journal of Cellular Physiology·N BresgenP M Eckl
Aug 15, 2002·Biochemical and Biophysical Research Communications·Magnus K R SamuelssonSam Okret
Sep 12, 2015·Cell Death & Disease·C LebeaupinB Bailly-Maitre
Mar 25, 2014·Theriogenology·Priscila P B SantanaMoysés S Miranda
Mar 31, 2009·Biochimica Et Biophysica Acta·Riccardo AutelliGabriella Bonelli
May 25, 2016·Molecular Pharmacology·Neil J McKenna
Feb 29, 2008·Drug Metabolism and Pharmacokinetics·Yun-Ping Lim, Jin-ding Huang
Nov 9, 2017·Molecular Pharmacology·Peter O Oladimeji, Taosheng Chen
May 16, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bryan MackowiakHongbing Wang
Jul 1, 2007·Expert Review of Endocrinology & Metabolism·Joana D AmaralCecília P Rodrigues
Apr 19, 2005·Molecular Pharmaceutics·Jayanth Panyam, Vinod Labhasetwar
Apr 10, 2017·Research in Veterinary Science·Mateusz MikiewiczTadeusz Rotkiewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis